Page last updated: 2024-09-02

1-hydroxymethylmidazolam and u 74006f

1-hydroxymethylmidazolam has been researched along with u 74006f in 1 studies

Compound Research Comparison

Studies
(1-hydroxymethylmidazolam)
Trials
(1-hydroxymethylmidazolam)
Recent Studies (post-2010)
(1-hydroxymethylmidazolam)
Studies
(u 74006f)
Trials
(u 74006f)
Recent Studies (post-2010) (u 74006f)
16346493624911

Protein Interaction Comparison

ProteinTaxonomy1-hydroxymethylmidazolam (IC50)u 74006f (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.718
Tyrosine-protein kinase FynHomo sapiens (human)1.116
Alpha-2C adrenergic receptorHomo sapiens (human)7.898
5-hydroxytryptamine receptor 2AHomo sapiens (human)2.002
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.718
Mitogen-activated protein kinase 14Homo sapiens (human)7.406

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleishaker, JC; Hopkins, NK; Pearson, LK; Pearson, PG; Peters, GR; Wienkers, LC1

Trials

1 trial(s) available for 1-hydroxymethylmidazolam and u 74006f

ArticleYear
Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Antioxidants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Body Weight; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Estrogens; Female; Hormone Replacement Therapy; Humans; Metabolic Clearance Rate; Midazolam; Middle Aged; Oxidoreductases, N-Demethylating; Postmenopause; Pregnatrienes; Premenopause; Progesterone

1999